VolitionRX Ltd
VNRX0.255USD
+0.009+3.50%
收盘 02/09, 16:00（美东）报价延迟15分钟
2.20M总市值
亏损市盈率 TTM
关于 VolitionRX Ltd 公司
VolitionRx Limited is a multi-national company focused on advancing the science of epigenetics. The Company is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and monitor a range of diseases, including cancers and diseases associated with NETosis, such as sepsis. Its key pillars are Nu.Q Vet, Nu.Q NETs, Nu.Q Discover, Nu.Q Cancer, and Capture-PCR. The Nu.Q Vet Cancer Test is commercially available as a cancer screening test in dogs. Nu.Q NETs is monitoring the immune system to save lives. Nu.Q Discover is a complete solution to profiling nucleosomes. Nu.Q Cancer monitoring disease progression, response to treatment and minimal residual disease. Capture-PCRTM is isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection.
VolitionRX Ltd简介
公司代码VNRX
公司名称VolitionRX Ltd
上市日期Feb 06, 2015
CEOButera (Salvatore Thomas)
员工数量85
证券类型Ordinary Share
年结日Feb 06
公司地址1489 West Warm Springs Road
城市HENDERSON
上市交易所NASDAQ OMX – NASDAQ Basic Amex
国家United States of America
邮编89014
电话17024251561
网址https://volition.com/
公司代码VNRX
上市日期Feb 06, 2015
CEOButera (Salvatore Thomas)
VolitionRX Ltd公司高管
名称
名称/职务
职务
持股
持股变动
Mr. Guy Archibald Innes
Mr. Guy Archibald Innes
Independent Director
Independent Director
2.99M
+12000.00%
Mr. Cameron John Reynolds
Mr. Cameron John Reynolds
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.38M
+74700.00%
Dr. Jacob Vincent Micallef
Dr. Jacob Vincent Micallef
Chief Scientific Officer
Chief Scientific Officer
480.16K
+35400.00%
Mr. Terig Hughes
Mr. Terig Hughes
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
437.35K
+49200.00%
Dr. Salvatore Thomas Butera
Dr. Salvatore Thomas Butera
Chief Executive Officer of Volition Vet
Chief Executive Officer of Volition Vet
378.80K
+53400.00%
Dr. Jasmine Kway
Dr. Jasmine Kway
Chief Executive Officer of Singapore Volition
Chief Executive Officer of Singapore Volition
245.61K
+42000.00%
Dr. Alan Colman, Ph.D.
Dr. Alan Colman, Ph.D.
Independent Director
Independent Director
215.55K
+12000.00%
Mr. Gael Forterre
Mr. Gael Forterre
Chief Commercial Officer
Chief Commercial Officer
189.87K
-2010.00%
Mr. Nicholas Plummer
Mr. Nicholas Plummer
Group General Counsel
Group General Counsel
189.64K
-5647.00%
Mr. Rodney Gerard Rootsaert
Mr. Rodney Gerard Rootsaert
Corporate Secretary
Corporate Secretary
162.26K
-3196.00%
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Guy Archibald Innes
Mr. Guy Archibald Innes
Independent Director
Independent Director
2.99M
+12000.00%
Mr. Cameron John Reynolds
Mr. Cameron John Reynolds
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
2.38M
+74700.00%
Dr. Jacob Vincent Micallef
Dr. Jacob Vincent Micallef
Chief Scientific Officer
Chief Scientific Officer
480.16K
+35400.00%
Mr. Terig Hughes
Mr. Terig Hughes
Chief Financial Officer, Treasurer
Chief Financial Officer, Treasurer
437.35K
+49200.00%
Dr. Salvatore Thomas Butera
Dr. Salvatore Thomas Butera
Chief Executive Officer of Volition Vet
Chief Executive Officer of Volition Vet
378.80K
+53400.00%
Dr. Jasmine Kway
Dr. Jasmine Kway
Chief Executive Officer of Singapore Volition
Chief Executive Officer of Singapore Volition
245.61K
+42000.00%
收入明细
由于公司未披露，未能获取相关数据
由于公司未披露，未能获取相关数据
业务
地区
由于公司未披露，未能获取相关数据
股东统计
更新时间: 2月5日 周四
更新时间: 2月5日 周四
持股股东
股东类型
持股股东
持股股东
占比
Lagoda Investment Management, L.P.
10.17%
Cotterford Co., Ltd.
9.78%
Armistice Capital LLC
7.64%
Innes (Guy Archibald)
2.44%
Reynolds (Cameron John)
1.94%
其他
68.04%
持股股东
持股股东
占比
Lagoda Investment Management, L.P.
10.17%
Cotterford Co., Ltd.
9.78%
Armistice Capital LLC
7.64%
Innes (Guy Archibald)
2.44%
Reynolds (Cameron John)
1.94%
其他
68.04%
股东类型
持股股东
占比
Investment Advisor
12.09%
Corporation
10.60%
Hedge Fund
8.00%
Individual Investor
7.00%
Investment Advisor/Hedge Fund
1.12%
Research Firm
0.04%
Venture Capital
0.03%
其他
61.13%
机构持股
更新时间: 1月1日 周四
更新时间: 1月1日 周四
报告期
机构数
持股数
持股占比
持股变动
2025Q4
58
26.12M
21.27%
+1.98M
2025Q3
57
23.92M
20.70%
+1.72M
2025Q2
78
41.39M
40.30%
+860.69K
2025Q1
83
44.42M
46.85%
+2.70M
2024Q4
82
41.53M
44.82%
+1.50M
2024Q3
82
38.59M
41.90%
+9.42M
2024Q2
82
28.77M
32.86%
+105.49K
2024Q1
84
28.22M
34.52%
+1.47M
2023Q4
87
26.17M
37.10%
+183.39K
2023Q3
91
25.37M
36.48%
-477.38K
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
Lagoda Investment Management, L.P.
12.49M
10.17%
+782.00K
+6.68%
Sep 30, 2025
Cotterford Co., Ltd.
12.01M
9.78%
--
--
Apr 25, 2025
Armistice Capital LLC
9.38M
7.64%
+887.35K
+10.45%
Sep 30, 2025
Innes (Guy Archibald)
2.98M
2.43%
+96.15K
+3.33%
Oct 14, 2025
Reynolds (Cameron John)
2.31M
1.88%
+20.00K
+0.87%
Nov 17, 2025
The Vanguard Group, Inc.
1.53M
1.25%
-94.68K
-5.83%
Sep 30, 2025
Concord International Inc.
1.01M
0.82%
--
--
Apr 25, 2025
Geode Capital Management, L.L.C.
878.17K
0.72%
+113.28K
+14.81%
Sep 30, 2025
Micallef (Jacob Vincent)
444.76K
0.36%
-5.85K
-1.30%
Oct 04, 2025
BlackRock Institutional Trust Company, N.A.
445.19K
0.36%
--
--
Sep 30, 2025
查看更多
持股ETF
更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
占比0%
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
除权除息日
类型
比率
暂无数据
公告日期
除权除息日
类型
比率
暂无数据
